Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-11-15
1990-03-20
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
049102079
ABSTRACT:
The dicarboxylic, heterocyclic and substituted benzoic acid alkylene bridged piperidyl amides and esters are serotonin M antagonists.
REFERENCES:
patent: 2478134 (1956-05-01), Stoll et al.
patent: 3170927 (1965-02-01), Nador et al.
patent: 3342826 (1967-09-01), Miller et al.
patent: 3405134 (1968-10-01), Judd
patent: 3702324 (1972-11-01), Skinner et al.
patent: 4093734 (1978-06-01), Kruger et al.
patent: 4213983 (1980-07-01), Hadley et al.
patent: 4273778 (1981-06-01), Hadley et al.
patent: 4459300 (1984-07-01), Watts
patent: 4499099 (1985-02-01), Watts
patent: 4657911 (1987-04-01), Imbert et al.
Chem Abstracts 205997w, (1983).
Chem. Abstracts 156533e, (1975).
J. of Amer. Chem. Soc., vol. 76, pp. 2855-2862, (1954).
Liebigs Ann. Chem. pp. 209-216, (1967).
Hoppe-Seyler's Z. Physiol. Chem., pp. 768-774, (1967).
J. of Het. Chem., vol. 16, pp. 625-631, (1979).
Chem. Abstracts, 14238q, (1971).
Chem. Abstracts, 123907n, (1979).
Chem. Abstracts, 22111t, (1967).
Chem. Abstracts, 209629q, (1983).
Journal of Med. Chem., vol. 21, No. 7, pp. 638-633, (1978).
Journal of Med. Chem., vol. 25, No. 2, pp. 145-152, (1982).
Pharm. Zeit, No. 40, pgs. 1455 and 1456, (1972).
Derwent Abstracts 0006591, (1963).
Acta. Chim. Acad. Scien., vol. 51, pp. 327-338, (1967).
Izv. Akad. Nauk. Arm. SSR, Biol. Nauk., vol. 15, No. 1/2, pp. 3-14 (corr. Chem. Abs. 5665g), (1962).
Acta. Biologica Szeged., vol. 21, pp. 113-125, (1975).
Chem. Abstracts 83522w., (1976).
Naunyn-Schmiedebergs Arch. Pharmacol. Exp. Path., vol. 259, pp. 34-44, (1967).
J. of Org. Chem., vol. 31, pp. 3482-3489, (1966).
Chem. Pharm. Bull., vol. 18, No. 10, pp. 2050-2057, (1970).
Khim.-Farm. Zh., vol. 7, No. 8, pp. 492-496, (1973).
J. of Pharm. Sciences, vol. 57, pp. 684 and 685 (1968).
Chem. Abstracts 22632h, (1960).
Proceedings of the B.P.S., pgs. 499 and 500, (Sep. 7th-9th, 1977).
Breuleux, legal representative by Gerald
Donatsch Peter
Engel Gunter
Hugi Bruno
Richardson Brian P.
Borovian Joseph J.
Dentz Bernard I.
Honor Robert S.
Lee Mary C.
Sharkin Gerald D.
LandOfFree
Method of treating psychosis with N-quinuclidinyl-benzamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating psychosis with N-quinuclidinyl-benzamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating psychosis with N-quinuclidinyl-benzamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-793093